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Deacetylation of HSD17B10 by SIRT3 regulates cell
growth and cell resistance under oxidative and
starvation stresses
Lu Liu1, Shuaiyi Chen1, Miao Yu1, Chenxu Ge1, Mengmeng Ren1, Boya Liu1, Xin Yang1, Thomas W. Christian Jr2,
Ya-Ming Hou2, Junhua Zou1, Wei-Guo Zhu3 and Jianyuan Luo1,4
Abstract
17-beta-hydroxysteroid dehydrogenase 10 (HSD17B10) plays an important role in mitochondrial fatty acid metabolism and
is also involved in mitochondrial tRNA maturation. HSD17B10 missense mutations cause HSD10 mitochondrial disease
(HSD10MD). HSD17B10 with mutations identified from cases of HSD10MD show loss of function in dehydrogenase activity
and mitochondrial tRNA maturation, resulting in mitochondrial dysfunction. It has also been implicated to play roles in the
development of Alzheimer disease (AD) and tumorigenesis. Here, we found that HSD17B10 is a new substrate of NAD-
dependent deacetylase Sirtuin 3 (SIRT3). HSD17B10 is acetylated at lysine residues K79, K99 and K105 by the
acetyltransferase CBP, and the acetylation is reversed by SIRT3. HSD17B10 acetylation regulates its enzymatic activity and
the formation of mitochondrial RNase P. Furthermore, HSD17B10 acetylation regulates the intracellular functions, affecting
cell growth and cell resistance in response to stresses. Our results demonstrated that acetylation is an important regulation
mechanism for HSD17B10 and may provide insight into interrupting the development of AD.
Introduction
17-beta-hydroxysteroid dehydrogenase 10 (HSD17B10),
encoded by HSD17B10, is a member of the short-chain
dehydrogenase superfamily1. HSD17B10 is the only family
member located in the mitochondria2. It catalyzes the
beta-oxidation of fatty acids, androgens, and estrogens,
contains 3-alpha-hydroxysteroid dehydrogenase activity,
and carries out oxidative conversions of 7-alpha-OH and
7-beta-OH bile acids3–5. HSD17B10 plays an important
role in mitochondrial fatty acid metabolism.
Besides mitochondrial dehydrogenase activity, HSD17B10
is also an essential subunit of human mitochondrial ribo-
nuclease P (RNase P), a complex involved in mitochondrial
tRNAmaturation6. RNase P is a protein complex that cleaves
tRNA molecules in their 5′-ends7. HSD17B10 (MRPP2),
together with TRMT10C (MRPP1), forms a subcomplex of
the mitochondrial RNase P, called the MRPP1–MRPP2
subcomplex8. The MRPP1–MRPP2 subcomplex acts as a
tRNA maturation platform. It is involved in the 5′-end
cleavage by the mitochondrial RNase P complex and is
responsible for the N1-methylation of adenosine and gua-
nosine at position 9 (m1A9 and m1G9, respectively) of
human mitochondrial tRNA8,9. The MRPP1–MRPP2 sub-
complex enhances the efficiency of mitochondrial tRNA 3′-
processing and presents the nascent tRNA to the mito-
chondrial CCA tRNA nucleotidyltransferase to assist the
maturation of mitochondrial tRNA10. Hence, HSD17B10
plays an important role in mitochondrial tRNA maturation.
HSD17B10, mapping at Xp11.2, is a highly conserved
gene across a large evolutionary distance from nematodes
to mammals, implying that HSD17B10 plays a crucial
role11. HSD17B10 missense mutations cause HSD10 mito-
chondrial disease (HSD10MD), with features including
progressive neurodegeneration, psychomotor retardation,
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loss of mental and motor skills, seizures, cardiomyopathy,
and vision and hearing impairment12. HSD17B10 with
mutations identified from cases of HSD10MD show loss of
function in dehydrogenase activity and mitochondrial tRNA
maturation, resulting in mitochondrial dysfunction13–15.
HSD17B10 has a special D-loop structure that interacts
with amyloid-beta (Aβ)16. In Alzheimer disease (AD),
HSD17B10 activity is inhibited by interacting with intra-
cellular Aβ which may contribute to the neuronal dys-
function associated with AD17.
Post-translational modification of proteins is of great
importance in regulating protein functions. A study showed
that Parkin can regulate mitochondrial abundance of
HSD17B10 in a ubiquitin-dependent manner to promote
mitochondrial elongation18. In our previous study, we iden-
tified HSD17B10 from NAD-dependent deacetylase Sirtuin 3
(SIRT3) complexes19. In this study, we show that HSD17B10
is deacetylated by SIRT3, and its function is regulated by its
acetylation levels. Our results suggest a post-translational
modification pathway that regulates the functions of
HSD17B10 and results in a change of cellular phenotype.
Materials and methods
Protein purification
Constructs were transfected into HEK293T cells by
Polyethyleneimine (PEI). After 48 h, cells were harvested
and lysed in BC200 buffer (200 mM NaCl, 20 mM pH7.3
Tris, 20% glycerol, 0.2% NP-40). Cell lysates were incu-
bated with anti-Flag M2 beads (Sigma, USA)/anti-HA
beads (Roche, Switzerland) at 4 °C overnight. The beads
were washed with BC100 four times and eluted with Flag
peptide (Sigma)/HA peptide (Roche) at 4 °C for 4 h.
GST and GST fusion proteins were expressed in Rosetta
(DE3) (CWBiotech, Beijing, China) bacterial cells, treated
with 0.8M IPTG (Sigma) at 37 °C for 4 h to induce fusion
protein expression. Bacterial cells were harvested and
suspended in 10–20mL PBS. The same volume of
BC1000 (1M NaCl, 20 mM Tris, 40% glycerol, 2% Triton
X-100) was added and bacterial cells were lysed by soni-
cation. The lysates were incubated with GST-agarose
beads (Novagen) at 4 °C overnight. The beads were
washed with BC100 four times and eluted with Glu-
tathione (GSH) at 4 °C for 4 h.
SDS-PAGE followed by Coomassie blue staining was used
to quantify the amount of proteins purified from bacteria
and/or cells. Bovine serum albumin (BSA) was diluted into
concentration gradients, used as protein standards.
Western blotting
HEK293T cells, HCT116 cells or U2OS cells were
harvested and lysed in BC100 buffer (100 mM NaCl,
20 mM pH7.3 Tris, 20% glycerol, 0.2% NP-40). Cell lysates
were incubated with anti-Flag M2 beads (Sigma, USA)/
anti-HA beads (Roche, Switzerland) at 4 °C overnight. For
endogenous immunoprecipitation, cell lysates were incu-
bated with 1 μg anti-HSD17B10 (Abcam, UK), anti-SIRT3
(Cell Signaling Technology, USA), or normal mouse IgG,
normal rabbit IgG (Santa Cruz Biotechnology, USA) at
4 °C overnight. Protein A/G agarose beads (Santa Cruz
Biotechnology, USA) were added into the lysates and
incubated at 4 °C for 8 h. Beads were washed with BC100
four times and eluted by 0.1M glycine (Sigma, USA) at
4 °C for 10min and neutralized with 1M Tris Base. The
elution was subjected to western blot and immunoblotted
with indicated antibodies.
All cell lines were bought from ATCC. The information
of antibodies was as follows: Anti-Flag (Sigma-Aldrich,
Cat#F-3165), Anti–HA (Thermo Fisher Scientific,
Cat#26183), Anti-HSD17B10 (Abcam, Cat#ab10260),
Anti-SIRT3 (Cell Signaling Technology, Cat#2627 S),
Anti-CBP (Cell Signaling Technology, Cat#7389 S), Anti-
pan acetyllysine (Cell Signaling Technology, Cat#9441 L),
Anti-β-actin (Santa Cruz Biotechnology, Cat#sc-47778),
Anti-DO-1 (Cell Signaling Technology, Cat#18032 S),
Anti-p62 (Proteintech, Cat#18420-1-AP), and Anti-LC3B
(Sigma-Aldrich, Cat#L7543).
GST pull-down and in vitro acetylation assay
Flag-tagged HSD17B10 and SIRT3 were purified from
HEK293T cells. GST and GST fusion proteins were purified
from Rosetta (DE3) bacterial cells and bound to GST-
agarose beads. Flag-tagged proteins and GST fusion pro-
teins were incubated in buffer BC200 at 4 °C overnight.
Beads were washed with BC100 four times and boiled in the
SDS sample buffer. The elution was subjected to western
blot and immunoblotted with indicated antibodies.
For in vitro acetylation assay, the GST fusion proteins
were purified from Rosetta (DE3) bacterial cells. The
reaction mixture contained 10 × Ac Buffer1 (200 mM
pH8.0 HEPES,10 mM DTT, 10 mM PMSF, 1 mg/ml BSA),
acetyl-CoA (17 ng/μl), CBP and GST fusion proteins. The
reaction mixture was incubated at 37 °C for 2 h and boiled
in the SDS sample buffer.
In vitro deacetylation assay
Flag-tagged HSD17B10 and SIRT3 were purified from
HEK293T cells. The reaction mixture contained 10×Ac
Buffer1, 2 × DeAc Buffer2 (8 mM MgCl2, 100 mM NaCl,
20% glycerol), and acetylated HSD17B10. SIRT3 and
NAD+ (1 mM) were present or absent as needed. The
reaction mixture was incubated at 37 °C for 2 h and boiled
in the SDS sample buffer.
HSD17B10 enzymatic activity assays
HSD17B10 dehydrogenase activity is measured in the
reverse direction for the reduction of acetoacetyl-CoA to
L-3-hydroxyacyl-CoA accompanied by the oxidation of
NADH to NAD+ 20. The assay mixture contains 0.1M
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pH7.0 potassium phosphate, 0.2 mg/ml bovine serum
albumin, 0.2 mM NADH, and various concentrations of
acetoacetyl-CoA (0–300 μM). The assay was started by
the addition of 50 nM HSD17B10. The decrease in
absorbance at 340 nm was measured. NADH standard
curve was established to measure substrate conversion.
Kinetic parameters were calculated from initial-velocity
by direct curve fitting using non-linear regression analysis,
and Michaelis–Menten plots were generated via Graph-
Pad Prism 7.0.
Generation of stable HSD17B10/SIRT3 CRISPR-Cas9 cell
lines
Single guide RNA (sgRNA) sequences were as follows:
SIRT3: 5′-CACCGCTCTACACGCAGAACATCGA-3′;




sgRNAs were cloned into LentiCRISPR-V2 vector, and
the plasmids were transfected with packaging plasmids
pSPAX2 and pMD.2 G (at 4:3:1 ratio) into HEK293T cells.
The medium was changed after 8–10 h. Viruses
were collected at 48 h post-transfection to infect target
cells (U2OS or HCT116). The infected cells were
selected for stable cell lines with 1 μg/ml puromycin for
2 weeks.
Knockdown of CBP
Small interfering RNA (siRNA) sequences were as follows:
1#: CGGCACAGCCUCUCAGUCA(dTdT)
2#: GAGGUCGCGUUUACAUAAA(dTdT)
siRNAs were transfected into HEK293T cells by
RNAiMAX (ThermoFisher, USA). The medium was
changed after 24 h. Cells were harvested at 48 h post-
transfection and lysed in BC100 buffer (100 mM NaCl,
20 mM pH7.3 Tris, 20% glycerol, 0.2% NP-40). Cell lysates
were incubated with anti-acetyllysine agarose (Immu-
nechem, Canada) at 4 °C overnight. Beads were washed
with BC100 four times and eluted by 0.1M glycine
(Sigma, USA) at 4 °C for 10min and neutralized with 1M
Tris Base. The elution was subjected to western blot and
immunoblotted with indicated antibodies.
Measurement of cellular NAD+/NADH levels
NAD+/NADH levels in HCT116 cells were measured
with the NAD/NADH Quantification Kit (Sigma, USA).
2 × 105 cells were collected for each assay. Cells were
extracted and samples were deproteinized before use in
assay. Samples were divided into two parts for NADtotal
and NADH only measurement. The absorbance at
450 nm (A450) was measured. All the samples were
run in triplicate. NAD+/NADH= (NADtotal−NADH)/
NADH.
RT-qPCR
Total RNA was extracted using Trizol reagent (Sigma,
USA). 2 μg RNA was reverse-transcribed into cDNA using
the Revertra ace qPCR RT Kit (TOYOBO, Japan). Real-
time PCR was performed in triplicate using AceQ qPCR
SYBR green master mix (Vazyme, Nanjing, China) by the
ABI 7500/7500 fast Real-Time PCR systems (Applied
Biosystems, ThermoFisher, USA). The amount of tRNA
was calculated by △△Ct method. The human 18S RNA
was used as the internal control. For pre-tRNAs, primers
were designed to span the cleavage sites. For mature
tRNAs, primers were designed within gene exon, and
therefore amplified both pre- and mature mitochondrial
tRNAs. The primers were as follows:
mt pre-tRNAPro: 5′-GATGGGTGAGTCAATACTTGG
G-3′ and 5′-CCATTAGCACCCAAAGCTAAGA-3′; mt
pre-tRNAVal: 5′-AGAGGAGACAAGTCGTAACATGG-3′
and 5′-GGTGCTTTGTGTTAAGCTACACTCTGG-3′; mt
pre-tRNAIle: 5′-GCGAATTCAATCTCCAGCA-3′ and 5′-G
AAATAAGGGGGTTTAAGC-3′; mt tRNAPro: 5′-TCAG
AGAAAAAGTCTTTAACTCCACC-3′ and 5′-ATAGTTT
AAATTAGAATCTTAGCTTTGGGT-3′; mt tRNAVal: 5′-G
TGTAGCTTAACACAAAGCACCC-3′ and 5′-TCAGAG
CGGTCAAGTTAAGTTG-3′; mt tRNAIle: 5′-TCTTTAT
ACAGACTATTTTC-3′ and 5′-TAGAAATAAGGGGG
TTTAAG-3′; 18S RNA: 5′-GCCGCTAGAGGTGAAA
TTCTT-3′ and 5′-CTTTCGCTCTGGTCCGTCTT-3′.
Mitochondrial membrane potential
HCT116 cells were grown in glass bottom cell culture
dish (φ20 mm, Nest, China) to 70% confluent. 200 nM
Mito Tracker Green (Invitrogen, USA) and 10 nM
TMRM (ThermoFisher, USA) were incubated with cells
for 30 min, followed by washing twice with HBSS media.
Cells were imaged live by confocal microscopy and the
intensity of fluorescence (ex: 490 nm, em: 516 nm for
Mito Tracker Green; ex: 490 nm, em: 550 nm for
TMRM) was recorded to determine the uncollapsed
proton gradient to measure mitochondrial membrane
potential.
Cell growth
HCT116 cells were seeded into six-well plates and were
counted every 24 h to establish cell growth curves.
HCT116 cells were seeded into 6 cm dishes. After cul-
turing for 7 days, cells were washed with PBS three times,
fixed with 4% paraformaldehyde, and stained with 0.2%
crystal violet. Pictures were shot to show colony forma-
tion. HCT116 cells were seeded into 96-well plates and
cultured for 48 h. 10 μl CCK-8 was added into 100 μl
DMEM (no phenol red, Gibco, USA) in each well. The
plate was incubated for 1 h in the incubator (37 °C, 5%
CO2). The absorbance at 450 nm (A450) was finally mea-
sured using microplate reader.
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Statistical analysis
Experiments in Figs. 1 and 2e, f were performed twice.
The other experiments were performed three times. The
repeated experiments showed similar results. Sample sizes
were regularly chosen as three replicates. Statistical analysis
was performed via Graphpad prism 7.0. Data were expres-
sed as mean ± standard deviation (S.D.) and S.D. was cal-
culated to estimate the variation within each group of data.
Results
HSD17B10 interacts with SIRT3
In our previous report, we purified SIRT3 complex by
immunoprecipitation and mass spectrometry. HSD17B10
was found in the complex19. To verify the interaction
between HSD17B10 and SIRT3, we overexpressed tagged
SIRT3 and HSD17B10 in HEK293T cells and performed
co-immunoprecipitation assays. SIRT3 can interact with
Fig. 1 HSD17B10 interacts with SIRT3. a Flag-tagged HSD17B10 and HA-tagged SIRT3 were transfected individually or together into HEK293T cells
followed by immunoprecipitation with M2 beads. b Flag-tagged SIRT3 and HA-tagged HSD17B10 were transfected individually or together into
HEK293T cells followed by immunoprecipitation with M2 beads. c Endogenous SIRT3 was IPed from HCT116 cells. Rabbit IgG was used as a control. d
Endogenous HSD17B10 was IPed from HCT116 cells. Mouse IgG was used as a control. e Flag-tagged HSD17B10 was transfected into HEK293T cells
followed by immunoprecipitation with M2 beads. Purified Flag-tagged HSD17B10 was incubated with GST/GST-SIRT3 and was IPed with GST-agarose
beads. f Flag-tagged SIRT3 was transfected into HEK293T cells followed by immunoprecipitation with M2 beads. Purified Flag-tagged SIRT3 was
incubated with GST/GST-HSD17B10 and was IPed with GST-agarose beads.
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HSD17B10 (Fig. 1a), and vice versa (Fig. 1b). SIRT3-
HSD17B10 interaction was further confirmed by the co-
immunoprecipitation of endogenous SIRT3 and
HSD17B10 (Fig. 1c, d). We also performed GST pull-
down assay to determine if HSD17B10 and SIRT3 can
directly interact with each other. The results showed that
GST-SIRT3 pulled down HSD17B10 (Fig. 1e) and GST-
HSD17B10 pulled down SIRT3 (Fig. 1f). Taken together,
we demonstrated that HSD17B10 directly interacts with
SIRT3 both in vivo and in vitro.
Fig. 2 HSD17B10 can be acetylated by CBP. a Flag-tagged HSD17B10 was co-transfected with vector or HA-tagged acetylase CBP, P300, MOF,
TIP60, or PCAF respectively as indicated. Relative HSD17B10 acetylation ratios were calculated after normalizing against Flag. b Flag-tagged
HSD17B10 was co-transfected with vector or HA-tagged CBP. Cells were treated with GAR (20 μM) for the indicated time. Relative HSD17B10
acetylation ratios were calculated after normalizing against Flag. c Flag-tagged HSD17B10 was co-transfected with different amounts of HA-tagged
CBP as indicated. Relative HSD17B10 acetylation ratios were calculated after normalizing against Flag. d CBP siRNA sequences were transfected into
HEK293T cells. Endogenous HSD17B10 was purified with anti-acetyllysine agarose, and acetylated HSD17B10 levels were determined by western blot
analysis. e Flag-tagged HSD17B10 and HA-tagged CBP were transfected individually or together into HEK293T cells followed by immunoprecipitation
with M2 beads. f HA-tagged CBP and Flag-tagged HSD17B10 were transfected individually or together into HEK293T cells followed by
immunoprecipitation with HA beads. The quantifications in a–d refer to the presented blots.
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HSD17B10 is acetylated by CBP
The interaction between HSD17B10 and SIRT3 promp-
ted us to consider whether HSD17B10 is a novel target of
SIRT3. Therefore, we first examined whether HSD17B10
could be acetylated. We co-transfected Flag-HSD17B10
with different acetyltransferases in HEK293T cells and
incubated the cell lysates with M2 beads to immunopreci-
pitate HSD17B10. HSD17B10 acetylation was detected
when co-transfected with CBP or p300, and CBP gave a
stronger acetylation signal (Fig. 2a). Hence, CBP is the
major acetyltransferase for HSD17B10. Garcinol (GAR) is a
common CBP acetylation activity inhibitor. Treating cells
with GAR for the indicated time inhibited HSD17B10
acetylation by CBP (Fig. 2b). Flag-tagged HSD17B10 co-
transfected with different amounts of HA-tagged CBP
showed that HSD17B10 acetylation increased as the
amount of CBP increased (Fig. 2c). siRNA knockdown of
CBP in HEK293T cells decreased acetylation levels of
HSD17B10 (Fig. 2d). Flag-tagged HSD17B10 and HA-
tagged CBP transfected individually or together into
HEK293T cells followed by immunoprecipitation showed
that HSD17B10 and CBP could interact with each other
(Fig. 2e, f). In conclusion, we demonstrated that HSD17B10
can be acetylated and CBP is the major acetyltransferase.
HSD17B10 is deacetylated by SIRT3
We further explored if SIRT3 can deacetylate
HSD17B10. We transfected Flag-tagged HSD17B10 into
HEK293T cells and treated cells with nicotinamide
(NAM) and Trichostatin A (TSA) individually or simul-
taneously for the indicated time. We found that
HSD17B10 acetylation levels were higher after treating
cells with NAM, a specific inhibitor of the sirtuins,
whereas treating with TSA, an inhibitor of other HDACs,
did not affect HSD17B10 acetylation (Fig. 3a). Meanwhile,
treating with NAM together with TSA did not further
enhance HSD17B10 acetylation compared to treating with
NAM alone (Fig. 3a). These results indicate that
HSD17B10 acetylation is regulated by the sirtuins family.
Study on HSD17B10 subcellular location shows that it is
distributed in mitochondria2. SIRT3, SIRT4, and SIRT5
are three mitochondrial members of the sirtuins family.
Thus, we co-transfected Flag-tagged HSD17B10 together
with HA-tagged SIRT3, SIRT4, or SIRT5 into
HEK293T cells. Compared to SIRT4 or SIRT5, SIRT3
gave the strongest deacetylation activity of HSD17B10
(Fig. 3b). Knockout of SIRT3 in U2OS cells showed
increased acetylation levels of HSD17B10 (Fig. 3c), indi-
cating that HSD17B10 is hyperacetylated in SIRT3
knockout cells. Flag-tagged HSD17B10 co-transfected
with different amounts of HA-tagged SIRT3 showed
that HSD17B10 acetylation decreased as the amount of
SIRT3 increased (Fig. 3d). We found that SIRT3 H248Y, a
SIRT3 catalytic center mutant, cannot deacetylate
HSD17B10 as much as SIRT3 WT (Fig. 3e). In addition,
we conducted an in vitro deacetylation assay and found
that SIRT3 can deacetylate HSD17B10 in vitro and the
deacetylation process is NAD+-dependent (Fig. 3f). Thus,
we concluded that SIRT3 can deacetylate HSD17B10 both
in vivo and in vitro.
Identify the major acetylation sites of HSD17B10
To identify the major acetylation sites of HSD17B10, we
purified acetylated HSD17B10 for mass spectrometry (MS)
(Fig. 4a). The result showed that K52, K53, K99, K105 and
K172 are putative acetylation sites. We further conducted
an in vitro acetylation assay. HSD17B10 was purposely
separated into three fractions as indicated in Fig. 4b.
HSD17B10 GST fusion protein N-terminus (NT), middle
(M) and full-length (FL) showed acetylation signal but not
C-terminus (CT), indicating that acetylation sites of
HSD17B10 are at NT and M fractions, which also excluded
CT located lysine residues K172 and K212. HSD17B10 is a
highly evolutionary conservation protein11, and conserved
lysine residue usually plays a critical role in protein acet-
ylation and can affect protein functions. We analyzed
HSD17B10 amino acid sequence conservation and identi-
fied K9, K79, K81, K99, K104 and K105 as highly conserved
lysines (Fig. 4c). We constructed KR mutant plasmid which
is a mimic for deacetylation status, and transfected WT and
KR mutant HSD17B10 into HEK293T cells to examine
their acetylation status. We found that K9R, K52R, K53R,
K79R, K99R and K105R decreased HSD17B10 acetylation
levels (Fig. 4d). Altogether, these data showed that K9, K52,
K53, K79, K99 and K105 are putative acetylation lysine
residues of HSD17B10.
HSD17B10 acetylation affects its enzymatic activity and
the formation of mt-tRNA splicing complex
HSD17B10 contains mitochondrial dehydrogenase
activity1, and acts as a component of mt-tRNA splicing
complex mitochondrial ribonuclease P6. We investigated if
HSD17B10 acetylation regulates these functions. We
purified deacetylated and hyperacetylated HSD17B10 to
carry out an in vitro enzymatic activity assay20. Kinetic
parameters were calculated from initial-velocity by direct
curve fitting using non-linear regression analysis.
Michaelis–Menten plots and kinetic parameters were
shown in Fig. S1. kcat/KM was calculated to represent
catalytic efficiency. Acetylation of HSD17B10 significantly
reduced its enzymatic activity compared to deacetylated
HSD17B10 (Fig. 5a). We then purified HSD17B10WT and
KR mutants which are putative acetylated lysine residues
of HSD17B10 (Fig. 4d) for the in vitro enzymatic activity
assay. Interestingly, we found that only K79R, K99R and
K105R dramatically increased HSD17B10 enzymatic
activity (Fig. 5b). Meanwhile, in terms of interaction with
TRMT10C, a component of mitochondrial ribonuclease P,
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Fig. 3 SIRT3 is the main deacetylase for HSD17B10. a Flag-tagged HSD17B10 was transfected into HEK293T cells, and cells were treated with
10 mM NAM and/or 1 μM TSA for the indicated time. Relative HSD17B10 acetylation ratios were calculated after normalizing against Flag. b Flag-
tagged HSD17B10 was co-transfected with vector or HA-tagged SIRT3/SIRT4/SIRT5 respectively as indicated. Relative HSD17B10 acetylation ratios
were calculated after normalizing against Flag. c Endogenous HSD17B10 was purified with anti-acetyllysine agarose in WT or SIRT3 knockout U2OS
cells. Acetylated HSD17B10 levels were determined by western blot analysis. d Flag-tagged HSD17B10 was co-transfected with different amounts of
HA-tagged SIRT3 as indicated. Relative HSD17B10 acetylation ratios were calculated after normalizing against Flag. e Flag-tagged HSD17B10 was co-
transfected with vector, HA-tagged WT SIRT3 or the catalytic center mutation SIRT3 H248Y respectively. Relative HSD17B10 acetylation ratios were
calculated after normalizing against Flag. f Flag-tagged HSD17B10 and SIRT3 were respectively transfected into HEK293T cells and were purified with
M2 beads. In vitro deacetylation assay was performed as indicated. Relative HSD17B10 acetylation ratios were calculated after normalizing against
Flag. The quantifications in this figure refer to the presented blots.
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HSD17B10 WT and KR mutants showed similar results.
K79R, K99R and K105R mutants promoted interaction
between TRMT10C and HSD17B10 more strikingly
(Fig. 5c).
Thus, we concluded that K79R, K99R and K105R are
three major functional acetylation lysine residues and
constructed multiple lysine mutant plasmids 3KR and
3KQ (mimic for hyperacetylation status) for further
investigation. We transfected WT and 3KR mutant
HSD17B10 into HEK293T cells treated with SIRT3 inhi-
bitor NAM, and 3KR acetylation levels were much
reduced (Fig. 5d). We then purified WT, 3KR and 3KQ
Fig. 4 Identify the main acetylation sites of HSD17B10. a Flag-tagged HSD17B10 was co-transfected with HA-tagged CBP, and cells were treated
with 10 mM NAM for 6 h. Whole-cell lysate was collected, IPed with M2 beads and eluted by Flag peptide. After SDS-PAGE gel separating and
Coomassie blue staining, the specific band for HSD17B10 was analyzed by mass spectrometry. b HSD17B10 GST N-terminal (NT), middle (M),
C-terminus (CT) and full-length (FL) plasmids were constructed, and in vitro acetylation assay was conducted. GST protein was used as a negative
control. c HSD17B10 amino acid sequence conservation was analyzed via sequence analyzing software MEGA. d HSD17B10 KR mutant (mimicking
the deacetylation status) plasmids were constructed. Flag-tagged HSD17B10 WT and KR mutants were individually transfected and cells were treated
with 10 mM NAM for 6 h. Relative HSD17B10 acetylation ratios were calculated after normalizing against Flag.
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HSD17B10 for in vitro enzymatic activity assay, and
HSD17B10 3KR mutant significantly enhanced its enzy-
matic activity compared to WT while 3KQ had the
opposite effect (Fig. 5e). Co-IP assay showed the same
result that 3KR mutant promoted interaction between
TRMT10C and HSD17B10 whereas 3KQ acted inversely
(Fig. 5f, g). Taken together, the above data demonstrated
that K79, K99 and K105 are three major functional acet-
ylation lysine residues of HSD17B10, and HSD17B10
acetylation affects its enzymatic activity and the formation
of mt-tRNA splicing complex.
HSD17B10 acetylation regulates the intracellular functions
To further investigate the physiological functions of
HSD17B10 acetylation, we first established HSD17B10
CRISPR-Cas9 knockout HCT116 cells. Knocking out
HSD17B10 in mice is embryonic lethal21, and we found that
knockout of HSD17B10 in cells also caused cell death.
Therefore, we only obtained HSD17B10 knockdown clones
(Fig. S2a). HSD17B10 functions as a mitochondrial dehy-
drogenase that catalyzes the beta-oxidation of androgens,
estrogens and fatty acids3–5. As a result, NAD+ will be
changed to NADH. Consistent with this, our results showed
that the NAD+/NADH ratio increased in HSD17B10
knockdown cells (Fig. S2b). Since knocking down HSD17B10
impaired the formation of mt-tRNA splicing complex, we
chose mt pre-tRNAPro, mt pre-tRNAVal, and mt pre-tRNAIle
as three representative substrates. The amounts of these pre-
tRNAs increased, as expected (Fig.S2c). Cells of HSD17B10-
deficient patients exhibit the loss of function in dehy-
drogenase activity and mitochondrial tRNA maturation,
resulting in mitochondrial dysfunction13–15. Additionally,
HSD17B10 has been proved to play a protective role for
mitochondrial function18,21,22. Therefore, we used tetra-
methylrhodamine methyl ester (TMRM) staining intensity as
an indicator for mitochondrial membrane potential. TMRM
is a cell-permeant, cationic, red-orange fluorescent dye that is
readily sequestered by active mitochondria, and in dysfunc-
tional mitochondria TMRM is released into cytoplasm and
the signal will disappear. We observed that, in HSD17B10
knockdown cells, TMRM staining intensity decreased, indi-
cating that mitochondrial function was impaired (Fig. S2d).
We then re-expressed empty vector, HSD17B10 WT,
3KR and 3KQ in HSD17B10 knockdown HCT116 cells
(Fig. 6a) to investigate whether HSD17B10 acetylation
affected its intracellular functions. To determine the effect
of HSD17B10 enzymatic activity on cellular NAD+/
NADH ratio, HSD17B10 K172A was served as an enzy-
matic negative control8. In Fig. 5, we demonstrated that
HSD17B10 acetylation affects its enzymatic activity and
the formation of mt-tRNA splicing complex. As expected,
re-expressing WT HSD17B10 decreased NAD+/NADH
ratio compared to vector, and 3KR mutant further
reduced the ratio, while 3KQ barely changed the ratio
compared to WT (Fig. 6b). Also, as shown in Fig. 6c, the
amounts of mt pre-tRNAPro, mt pre-tRNAVal and mt pre-
tRNAIle decreased with the re-expression of HSD17B10
WT and 3KR, while 3KQ only slightly changed their
amounts compared to empty vector. Consistently, mito-
chondrial function was rescued by HSD17B10 WT and
3KR, while 3KQ had less effect (Fig. 6d). Taken together,
we demonstrated that HSD17B10 acetylation regulated
the mitochondrial function.
HSD17B10 acetylation affects cell growth and cell
resistance under stresses
HSD17B10 expression level has been proved to impact cell
growth22. We established cell growth curve, CCK-8 and
colony formation assays to verify that HSD17B10 knock-
down HCT116 cells indeed had a slower proliferation rate
(Fig. S3a–c). Re-expressing empty vector, HSD17B10 WT,
3KR and 3KQ in HSD17B10 knockdown HCT116 cells, we
found that re-expression of WT HSD17B10 promoted cell
growth and 3KR enhanced this effect compared to vector,
while cells re-expressed with 3KQ had a slower cell growth
rate compared to cells re-expressed with WT (Fig. 7a, b, c).
HSD17B10 deficiency may induce cell apoptosis and
overexpression of HSD17B10 can promote cell resistance to
(see figure on previous page)
Fig. 5 HSD17B10 acetylation affects its enzymatic activity and the formation of mt-tRNA splicing complex. a Flag-tagged HSD17B10 was
transfected into HEK293T cells, and cells were treated with or without 10 mM NAM for 6 h for deacetylated and hyperacetylated HSD17B10
purification. The L-3-hydroxyacyl-CoA dehydrogenase activity assay of HSD17B10 was conducted with acetoacetyl-CoA as the substrate and NADH as
the cofactor, and changes of the absorbance at 340 nm were measured to show the decrease of NADH. kcat/KM was calculated to represent catalytic
efficiency. Data were shown as mean ± S.D. (n= 3). b Flag-tagged HSD17B10 WT and KR mutants were individually transfected, and cells were
treated with 10 mM NAM for 6 h. The L-3-hydroxyacyl-CoA dehydrogenase activity of HSD17B10 was measured as previously described. Data were
shown as mean ± S.D. (n= 3). c Flag-tagged HSD17B10 WT and KR mutants were co-transfected with HA-tagged TRMT10C into HEK293T cells
followed by immunoprecipitation with M2 beads. d Flag-tagged HSD17B10 WT and 3KR were transfected into HEK293T cells, and cells were treated
with 10 mM NAM for 6 h. Relative HSD17B10 acetylation ratios were calculated after normalizing against Flag. e Flag-tagged HSD17B10 WT, 3KR and
3KQ were individually transfected. The L-3-hydroxyacyl-CoA dehydrogenase activity of HSD17B10 was measured as previously described. Data were
shown as mean ± S.D. (n= 3). f Flag-tagged HSD17B10 WT and 3KR were co-transfected with HA-tagged TRMT10C into HEK293T cells followed by
immunoprecipitation with M2 beads. g Flag-tagged HSD17B10 WT and 3KQ were co-transfected with HA-tagged TRMT10C into HEK293T cells
followed by immunoprecipitation with M2 beads.
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stress13,22. SIRT3, the deacetylase of HSD17B10, is a stress-
responsive factor as a deacetylase23–25. To find if HSD17B10
acetylation regulates cell resistance to stress and whether
SIRT3 participates in the process, we first treated cells with
H2O2, Earle’s Balanced Salt Solution (EBSS) and serum
starvation (SS) which can normally induce mitochondrial
dysfunction. The results showed that HSD17B10 acetylation
decreased, the level of SIRT3 expression increased, and the
Fig. 6 HSD17B10 acetylation regulates the intracellular functions. a Vector, Flag-tagged HSD17B10 WT, 3KR, 3KQ and K172A were individually
transfected into HSD17B10 knockdown HCT116 cells. Endogenous and re-expressed HSD17B10 were detected with HSD17B10 antibody. b The
absorbance at 450 nm was measure to quantify NADH and NADtotal in HSD17B10 knockdown HCT116 re-expressed with vector, Flag-tagged
HSD17B10 WT, 3KR and 3KQ cells. NAD+/NADH= (NADtotal− NADH)/NADH. Data were shown as mean ± S.D. (n= 3). K172A was used as an
enzymatic negative control. c The amounts of representative mt pre- and total tRNAs in HSD17B10 knockdown HCT116 re-expressed with vector,
Flag-tagged HSD17B10 WT, 3KR and 3KQ cells were confirmed by qPCR. Data were shown as mean ± S.D. (n= 3). d HSD17B10 knockdown HCT116
re-expressed with vector, Flag-tagged HSD17B10 WT, 3KR, and 3KQ cells were stained with TMRM (10 nM) and Mitotracker (200 nM) for 0.5 h.
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interaction between HSD17B10 and SIRT3 became stron-
ger under these treatments (Fig. 7d), demonstrating that
SIRT3 could deacetylate HSD17B10 under stresses. Since
HSD17B10 acetylation changed under stresses, we assumed
that HSD17B10 acetylation might regulate cell resistance in
response to stresses. We counted living cells after the
treatments and verified that HSD17B10 knockdown cells
lacked the resistance under stresses (Fig. S3d). With re-
expression of HSD17B10 WT and 3KR, cell resistance was
promoted under stresses compared to empty vector, while
cells re-expressed with 3KQ were less resistant under
stresses compared to WT (Fig. 7e). Taken together,
HSD17B10 acetylation can affect cell growth and cell
resistance in response to stresses.
Discussion
HSD17B10 is a member of short-chain dehydrogenase
family as well as an essential subunit of human mitochondrial
RNase P, an enzyme responsible for mitochondrial tRNA
maturation. HSD17B10 is a highly conserved gene across a
large evolutionary distance, and the missense mutations
cause the loss of function in dehydrogenase activity and
mitochondrial tRNA maturation, resulting in HSD10MD.
HSD17B10 plays an important role in mitochondrial fatty
acid metabolism and mitochondrial tRNAmaturation. In this
study, we identified HSD17B10 as a direct target of histone
deacetylase SIRT3. Hypoacetylated HSD17B10 mediated by
SIRT3 increased its enzymatic activity and mitochondrial
RNase P formation. This regulation resulted in increased cell
growth and cell resistance in response to stresses. Our study
demonstrated that acetylation of HSD17B10 regulates its
functions and results in a change of cellular phenotype.
HSD17B10 is a mitochondria-located protein and our
data showed that NAM, a specific inhibitor of the sirtuins,
enhanced its acetylation (Fig. 3a). SIRT3, SIRT4 and SIRT5
are three sirtuins reside within the mitochondria. Over-
expression of SIRT3, SIRT4 and SIRT5 can all deacetylate
HSD17B10 to different degrees (Fig. 3b). However, SIRT3
had the strongest deacetylation activity to HSD17B10. Yang
et al.26 found that there is an overlap in proteins associated
with SIRT3, SIRT4 and SIRT5 and these three mitochon-
dria sirtuins constitute the mitochondrial sirtuins network.
Indeed, we also found that HSD17B10 exists in SIRT5
complex27. Additionally, SIRT4 could down-regulate
HSD17B10 (Fig. 3b), indicating that SIRT4 may also play
an important role in regulating HSD17B10 functions. These
observations may be worth further investigation regarding
HSD17B10 function regulation.
It has been reported that HSD17B10 can be regulated by
Parkin for mitochondrial abundance in a ubiquitin-
dependent manner18. As acetylation can stabilize the pro-
tein by inhibiting its ubiquitination28, it is possible that
HSD17B10 acetylation could affect its ubiquitination.
However, our data did not implicate that acetylation can
affect HSD17B10 abundance. It seems that these two post-
translational modifications do not have cross talk in reg-
ulating its functions; it could be that they are occurred at
different lysine sites. Further exploration of other post-
translational modifications for HSD17B10 function regula-
tion and their disease relevance would be worthwhile.
Missense mutations identified in HSD10MD cases have
been verified to impair HSD17B10 dehydrogenase activity
and mitochondrial RNase P function, thus impairing
mitochondrial integrity and inducing apoptosis13,15,21.
However, these mutations do not influence the acetylation
of HSD17B10 (data not shown). HSD17B10 acetylation
mutants 3KR (mimic for hypoacetylation status) and 3KQ
(mimic for hyperacetylation status) were proved to affect its
enzymatic activity and mitochondrial RNase P formation
(Fig. 5e–g). As a consequence, HSD17B10 acetylation
changes cell NAD+/NADH ratio and the amount of mt pre-
tRNAs. Also, the mitochondrial membrane potential alters
with the changes of HSD17B10 acetylation, indicating the
dysfunction of mitochondria. It is possible that mutations in
acetylation sites of HSD17B10 could lead to HSD10MD.
HSD17B10 may contribute to the neuronal dysfunc-
tion associated with Alzheimer disease (AD) by inter-
acting with intracellular amyloid-beta (Aβ), and binding
with Aβ can inhibit HSD17B10 activity17,29. Our data
showed that acetylation of HSD17B10 can interrupt its
interaction with TRMT10C to affect the formation of
mt-tRNA splicing complex (Fig. 5f, g). As protein acet-
ylation often affects protein–protein interaction, it will
be interesting to investigate if acetylation of HSD17B10
can interfere the interaction of HSD17B10 and Aβ to
affect the development of AD.
Overexpression of HSD17B10 has been proved to
increase cell growth and resistance to cell death22. As
(see figure on previous page)
Fig. 7 HSD17B10 acetylation affects cell growth and cell resistance under stresses. a 5 × 104 HSD17B10 knockdown HCT116 re-expressed with
vector, Flag-tagged HSD17B10 WT, 3KR and 3KQ cells were seeded into six-well plates. Cell number was counted every 24 h. Data were shown as
mean ± S.D. (n= 3). b 5 × 103 HSD17B10 knockdown HCT116 re-expressed with vector, Flag-tagged HSD17B10 WT, 3KR and 3KQ cells were seeded
into 96-well plates. Cell growth was measured by CCK-8 assay after 48 h. Data were shown as mean ± S.D. (n= 3). c 5 × 103 HSD17B10 knockdown
HCT116 re-expressed with vector, Flag-tagged HSD17B10 WT, 3KR and 3KQ cells were seeded into 6 cm plates. Colony formation was shown after
crystal violet staining. d Flag-tagged HSD17B10 was transfected into HCT116 cells, and cells were treated with different stresses for the indicated time.
HSD17B10 was IPed with M2 beads. e 2 × 10
5 HSD17B10 knockdown HCT116 re-expressed with vector, Flag-tagged HSD17B10 WT, 3KR and 3KQ cells
were seeded into six-well plates. After 24 h, cells were treated with different stresses for the indicated time, and the number of living cells was
counted. Data were shown as mean ± S.D. (n= 3).
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expected, HSD17B10 acetylation can regulate cell
growth. SIRT3 is a stress-responsive deacetylase and we
have proved that HSD17B10 acetylation plays a reg-
ulatory role in maintaining mitochondrial membrane
potential. HSD17B10 acetylation levels decreased under
stresses, and SIRT3 acts as the deacetylase. Deacetylated
HSD17B10 protected cells from apoptosis under stres-
ses comparing with acetylated HSD17B10 (Fig. 7d, e).
Our study provides a possible mechanism for how
HSD17B10 functions in cell growth and protecting cells
from apoptosis. The results demonstrated that acetyla-
tion is an important regulation mechanism for
HSD17B10 and may provide insight into interrupting
the development of Alzheimer disease.
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